Neuren Pharmaceuticals | NEU - Cash And Equivalent

Stock Price
11.93
Daily Change
-0.27 -2.21%
Monthly
2.58%
Yearly
3.20%
Q2 Forecast
12.10

Neuren Pharmaceuticals reported AUD5.91M in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
Akebia Therapeutics USD 184.84M 18.4M Dec/2025
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Avita Medical AUD 10.24M 1.98M Dec/2025
Clinuvel Pharmaceuticals AUD 35.2M 3.62M Jun/2024
Dianthus Therapeutics USD 51.09M 4.9M Dec/2025
Genetic Signatures AUD 7.47M 33.32M Jun/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
Medical Developments International AUD 17.84M 219K Jun/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Organon & Co USD 672M 73M Sep/2025
Paradigm Biopharmaceuticals AUD 16.82M 1M Jun/2025
PYC Therapeutics AUD 153.05M 103.8M Jun/2025
Starpharma Holdings AUD 15.41M 4.87M Jun/2025
Tectonic Therapeutic USD 253.8M 14.64M Dec/2025
Telix Pharmaceuticals AUD 207.16M 503.19M Jun/2025
Viatris USD 1.32B 347.1M Dec/2025
Xeris Pharmaceuticals USD 111.04M 19.44M Dec/2025